Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...
Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’
Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ...
pharmaphorum9d
Moderna unveils $500m plan for African vaccine facility
Moderna has said it plans to invest $500 million ... The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug ...
mlive10d
Still ‘no red flags’ for COVID vaccine after years of monitoring their safety
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
STAT19d
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
based Moderna by the Biomedical Advanced Research ... there isn’t sufficient capacity to rapidly produce enough doses to meet global demand in a pandemic. “So that’s why the need for ...
Nasdaq21d
Moderna Unusual Options Activity
Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 trades. If we consider the specifics of ...
pharmaphorum4d
Moderna banks on OpenAI to accelerate mRNA research
Moderna has deployed over 750 GPTs across the company, including assistants for advanced analytics, image generation, and various other tasks. Among these is Dose ID GPT, which aids clinical ...